TGFB1 and chronic kidney disease: As shown in Figures 7(a) and 7(b), SP60012, SB203580, or PD98059 significantly inhibited the expression of TGF-β, COL-1, MyHC, and ANP, respectively, which was stimulated by CKD serum.